100 related articles for article (PubMed ID: 2247912)
1. Are three substages of clinical B prostate carcinoma useful in predicting disease-free survival?
Glick AJ; Philput CB; el Mahdi A; Ladaga L; Schellhammer PF
Urology; 1990 Dec; 36(6):483-7. PubMed ID: 2247912
[TBL] [Abstract][Full Text] [Related]
2. Radical prostatectomy and adjuvant radioactive gold seed placement: results of treatment at 5 and 10 years for clinical stages A2, B1 and B2 cancer of the prostate.
Kwon ED; Loening SA; Hawtrey CE
J Urol; 1991 Mar; 145(3):524-31. PubMed ID: 1997703
[TBL] [Abstract][Full Text] [Related]
3. Prognostic factors in prostate cancer. Analysis of 874 patients treated with radiation therapy.
Zagars GK; von Eschenbach AC; Ayala AG
Cancer; 1993 Sep; 72(5):1709-25. PubMed ID: 7688659
[TBL] [Abstract][Full Text] [Related]
4. Expectant management of localized prostatic cancer.
Whitmore WF; Warner JA; Thompson IM
Cancer; 1991 Feb; 67(4):1091-6. PubMed ID: 1991257
[TBL] [Abstract][Full Text] [Related]
5. Iodine 125 seed implants for prostatic carcinoma. Five- and ten-year follow-up.
Weyrich TP; Kandzari SJ; Jain PR
Urology; 1993 Feb; 41(2):122-6. PubMed ID: 8497980
[TBL] [Abstract][Full Text] [Related]
6. Improved local control and survival for surgically staged patients with locally advanced prostate cancer treated with up-front low dose rate iridium-192 prostate implantation and external beam irradiation.
Stromberg J; Martinez A; Benson R; Garton G; Diokno A; Gonzalez J; Zincke H; Schray M; Edmundson G; Brabbins D
Int J Radiat Oncol Biol Phys; 1994 Jan; 28(1):67-75. PubMed ID: 8270460
[TBL] [Abstract][Full Text] [Related]
7. Operable prostatic carcinoma: correlations among clinical stage, pathological stage, gleason histological score and early disease-free survival.
Fowler JE; Mills SE
J Urol; 1985 Jan; 133(1):49-52. PubMed ID: 3964879
[TBL] [Abstract][Full Text] [Related]
8. Morbidity and mortality of local failure after definitive therapy for prostate cancer.
Schellhammer PF; Whitmore RB; Kuban DA; el-Mahdi AM; Ladaga LA
J Urol; 1989 Mar; 141(3):567-71. PubMed ID: 2918594
[TBL] [Abstract][Full Text] [Related]
9. Long-term results of retropubic permanent 125iodine implantation of the prostate for clinically localized prostatic cancer.
Zelefsky MJ; Whitmore WF
J Urol; 1997 Jul; 158(1):23-9; discussion 29-30. PubMed ID: 9186315
[TBL] [Abstract][Full Text] [Related]
10. The effect of overall treatment time on local control in patients with adenocarcinoma of the prostate treated with radiation therapy.
Amdur RJ; Parsons JT; Fitzgerald LT; Million RR
Int J Radiat Oncol Biol Phys; 1990 Dec; 19(6):1377-82. PubMed ID: 2262361
[TBL] [Abstract][Full Text] [Related]
11. Potential benefit of improved local tumor control in patients with prostate carcinoma.
Kuban DA; el-Mahdi AM; Schellhammer PF
Cancer; 1995 May; 75(9):2373-82. PubMed ID: 7536125
[TBL] [Abstract][Full Text] [Related]
12. The role of serum prostatic acid phosphatase in the management of adenocarcinoma of the prostate with radiotherapy.
Carlton JC; Zagars GK; Oswald MJ
Int J Radiat Oncol Biol Phys; 1990 Dec; 19(6):1383-8. PubMed ID: 2262362
[TBL] [Abstract][Full Text] [Related]
13. Prostate-specific antigen and external beam radiation therapy in prostate cancer.
Zagars GK; Sherman NE; Babaian RJ
Cancer; 1991 Jan; 67(2):412-20. PubMed ID: 1702349
[TBL] [Abstract][Full Text] [Related]
14. MR imaging evaluation with a transrectal surface coil of local recurrence of prostatic cancer in men who have undergone radical prostatectomy.
Silverman JM; Krebs TL
AJR Am J Roentgenol; 1997 Feb; 168(2):379-85. PubMed ID: 9016212
[TBL] [Abstract][Full Text] [Related]
15. Iodine-125 implants versus external beam therapy for stages A2, B, and C prostate cancer.
Morton JD; Peschel RE
Int J Radiat Oncol Biol Phys; 1988 Jun; 14(6):1153-7. PubMed ID: 3133328
[TBL] [Abstract][Full Text] [Related]
16. The T classification of clinically localized prostate cancer. An appraisal based on disease outcome after radiation therapy.
Zagars GK; Geara FB; Pollack A; von Eschenbach AC
Cancer; 1994 Apr; 73(7):1904-12. PubMed ID: 7511040
[TBL] [Abstract][Full Text] [Related]
17. Rotational 3D-conformal radiation therapy (conformation therapy) combined with hormone therapy for the treatment of stage B2/C prostate cancer in Japanese men.
Karasawa K; Kaizu T; Niibe Y; Igaki H; Shinohara M; Tanaka Y; Matsuda T
Int J Radiat Oncol Biol Phys; 2003 May; 56(1):208-12. PubMed ID: 12694840
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the efficacy of local therapies for localized prostate cancer in the prostate-specific antigen era: a large single-institution experience with radical prostatectomy and external-beam radiotherapy.
Kupelian PA; Elshaikh M; Reddy CA; Zippe C; Klein EA
J Clin Oncol; 2002 Aug; 20(16):3376-85. PubMed ID: 12177097
[TBL] [Abstract][Full Text] [Related]
19. The predictive accuracy of staging transurethral resection of the prostate in the management of stage A cancer of the prostate: a comparative evaluation.
Lowe BA; Barry JM
J Urol; 1990 Jun; 143(6):1142-5. PubMed ID: 2342175
[TBL] [Abstract][Full Text] [Related]
20. Radical external beam radiation therapy for prostate carcinoma.
Garrett PG; Herman JG; Rawlings GA; Hawkins NV; Gospodarowicz MK; Keen CW; Rider WD
J Can Assoc Radiol; 1984 Jun; 35(2):139-43. PubMed ID: 6480665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
